Medical News

RSS

CPRIT awards cancer research grants to 13 Texas institutions

The Cancer Prevention and Research Institute of Texas (CPRIT), the second largest funding source of cancer research in the United States, kicks off its second year by awarding 52 cancer research grants totaling $40,302,026 to 13 Texas institutions. Among the grants are two CPRIT Scholars in Cancer Research recruitment awards bringing outstanding scientists from preeminent institutions to join the faculty at Texas universities.

30 Oct 2010

BioMedix receives ONC-ATCB 2011/2012 certification for TRAKnet Practice Management Software

BioMedix announced today that TRAKnet Practice Management Software 2.0 is 2011/2012 compliant and was certified as a Complete EHR on October 28th, 2010 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable Eligible Provider certification criteria adopted by the Secretary of Health and Human Services.

30 Oct 2010

Alnylam to present data on RNAi therapeutics for fibrotic diseases at The Liver Meeting

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it will present several poster presentations at the 61st Annual Meeting of the American Association for the Study of Liver Diseases being held in Boston, Mass from October 29 - November 2, 2010.

30 Oct 2010

Races tighten over health overhaul issues as clock ticks down to midterm elections

Races around the nation are being scrutinized for what the outcomes might mean for the health overhaul after next week's midterm elections.

30 Oct 2010

Researchers to investigate new drugs for parasitic disease

Urgently-needed new treatment for a parasitic disease is being investigated in research led at the University of Strathclyde in Glasgow, Scotland. Human African Trypanosomiasis, also known as sleeping sickness, affects between 50,000 and 70,000 people in Africa and South America. It is transmitted through the bite of the tsetse fly and attacks the nervous system and brain, leading to fever, headaches and disturbed sleep patterns.

30 Oct 2010

Progress update on Johnson & Johnson and Crucell's public offer

Pursuant to the provisions of Section 7 paragraph 1(a) of the Dutch Decree on Public Takeover Bids (Besluit Openbare Biedingen Wft) requiring a public announcement within four weeks following the announcement of an intended public offer to provide a status update, Johnson & Johnson (NYSE: JNJ) and Crucell N.V. provide the following joint update.

30 Oct 2010

Lancet series examines malaria eradication goal

Eliminating malaria can be achieved only with repeated investment over the long term and will require a major shift in policy and funding, according to some experts, Reuters reports.

30 Oct 2010

Hikma to acquire Baxter's US generic injectables business

Hikma Pharmaceuticals PLC ("Hikma"), the fast growing multinational pharmaceutical group, announces that it has signed an agreement to acquire Baxter Healthcare Corporation's US generic injectables business ("Multi-Source Injectables" or the "Business") for a cash consideration of $112 million.

30 Oct 2010

Adesso enters multi-year contract with Novartis

Adesso Solutions, the leader in integrated technology solutions for the Consumer Goods industry, today announced that a new multi-year contract has been signed with global pharmaceutical leader, Novartis AG.

30 Oct 2010

Idera presents data on TLR 3 agonist as vaccine adjuvants at Immunological Meeting

Idera Pharmaceuticals, Inc. today announced a presentation describing the chemistry and immunological activity of its proprietary Toll-Like Receptor (TLR) 3 agonist compounds and the use of these compounds as vaccine adjuvants in a preclinical model.

30 Oct 2010

Health reform implementation: Insurance options, states and exchanges, ACOs

Provisions of the health law that have already been implemented will change next year's insurance offerings -- so employees should pay attention to their options during open season, U.S. News & World Report writes. "You may be able to take advantage of some benefits that kicked in over the past few months under the new health reform law.

30 Oct 2010

NeoPharm enters merger agreement with Insys Therapeutics

NeoPharm, Inc. a biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for cancer and other diseases, today announced it has entered into a merger agreement with Insys Therapeutics, a Phoenix-based drug development company focused on pain and oncology.

30 Oct 2010

Advaxis enters CRADA with NCI for development of live attenuated Listeria vaccines

Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, is pleased to announce it has signed a formal research agreement with the National Cancer Institute at the National Institutes of Health.

30 Oct 2010

Women with type O blood linked to low egg numbers

In a study presented earlier this week at the American Society of Reproductive Medicine Conference in Denver, researchers at Yale and Albert Einstein College of Medicine measured levels of a chemical called follicle-stimulating hormone (FSH) in 560 women undergoing fertility treatments and found that those women with type O blood had chemical signs linked to low egg numbers.

30 Oct 2010

Providers brace for health overhaul, seek to improve quality

The (Torrance, Calif.) Daily Breeze: "With health care reform on the way -- bringing with it scores of new Medi-Cal patients -- community clinics that treat mostly low-income and uninsured patients are looking at ways to transform into primary care medical hubs. South Bay Family Health Care, based in Redondo Beach, will get help doing that from Los Angeles County's only public health insurance plan, L.A. Care. The nonprofit health plan has hired a consulting firm to help 11 clinics improve their treatment model over the next two years" (Evans, 10/28).

30 Oct 2010

Bed rest may harm mother and baby in pregnancy complications

Bed rest may not be the best option for preventing preterm labor and may even cause harm to the mother and baby, according to an integrative literature review in a special issue on "Women's Health Across the Lifespan" in Biological Research for Nursing (published by SAGE).

30 Oct 2010

HHS approves hundreds more local Gov'ts, businesses, unions for early retiree health program

The federal Department of Health and Human Services is still accepting applications for the $5 billion program to help cover the cost of retiree health care, the National Journal reports. The agency says 700 more employers have joined the program, raising the total to 3,600.

30 Oct 2010

Roche announces U.S. introduction of cobas e 602 analyzer

Roche announced today the U.S. introduction of the cobas e 602 analyzer, the latest addition to the cobas 8000 modular analyzer series for diagnostic labs with high-volume workloads. Labs will now be able to combine this new immunoassay module with two existing clinical chemistry modules to create an integrated platform with 24 unique system configurations to match their specific testing needs.

From Roche Sequencing and Life Science 30 Oct 2010

UB endocrinologist receives Junior Faculty Award to study effects of low testosterone in young men with type 2 diabetes

An endocrinologist in the University at Buffalo's School of Medicine and Biomedical Sciences has received a three-year $400,000 Junior Faculty Award from the American Diabetes Society to study the effects of low testosterone levels in young men with type 2 diabetes.

30 Oct 2010

Agilent opens new life sciences instruments manufacturing facility in Singapore

Agilent Technologies Inc. today announced the opening of its new life sciences instruments manufacturing facility in Singapore. The facility will produce the company's Liquid Chromatography/Mass Spectrometry (LC/MS) instruments for the global market.

30 Oct 2010

Medical News

CPRIT awards cancer research grants to 13 Texas institutions

BioMedix receives ONC-ATCB 2011/2012 certification for TRAKnet Practice Management Software

Alnylam to present data on RNAi therapeutics for fibrotic diseases at The Liver Meeting

Races tighten over health overhaul issues as clock ticks down to midterm elections

Researchers to investigate new drugs for parasitic disease

Progress update on Johnson & Johnson and Crucell's public offer

Lancet series examines malaria eradication goal

Hikma to acquire Baxter's US generic injectables business

Adesso enters multi-year contract with Novartis

Idera presents data on TLR 3 agonist as vaccine adjuvants at Immunological Meeting

Health reform implementation: Insurance options, states and exchanges, ACOs

NeoPharm enters merger agreement with Insys Therapeutics

Advaxis enters CRADA with NCI for development of live attenuated Listeria vaccines

Women with type O blood linked to low egg numbers

Providers brace for health overhaul, seek to improve quality

Bed rest may harm mother and baby in pregnancy complications

HHS approves hundreds more local Gov'ts, businesses, unions for early retiree health program

Roche announces U.S. introduction of cobas e 602 analyzer

UB endocrinologist receives Junior Faculty Award to study effects of low testosterone in young men with type 2 diabetes

Agilent opens new life sciences instruments manufacturing facility in Singapore

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News